-
Je něco špatně v tomto záznamu ?
Evaluation of physicochemical and stability properties of human growth hormone upon enzymatic PEGylation
Bahman Khameneh, Mohammad Reza Saberi, Mohammad Hassanzadeh-Khayyat, Hamid Mohammadpanah, Morteza Ghandadi, Mehrdad Iranshahi, Ali Baratian, Mahmoud Reza Jaafari
Jazyk angličtina Země Česko
Typ dokumentu práce podpořená grantem
- MeSH
- lékové transportní systémy MeSH
- lidský růstový hormon * farmakokinetika farmakologie chemie MeSH
- nosiče léků MeSH
- polyethylenglykoly farmakokinetika MeSH
- stabilita proteinů MeSH
- transglutaminasy farmakologie MeSH
- Publikační typ
- práce podpořená grantem MeSH
Background PEGylation is an increasingly important strategy for improving stability, pharmacokinetic and pharmacodynamic properties of proteins. Objective In this study, site-specific PEGylated human growth hormone (hGH) was prepared by microbial transglutaminase and physicochemical and stability properties of bioconjugates were tested. Method hGH was PEGylated by 20 kDa mPEG-NH2. PEG-hGH was purified by size exclusion chromatography method and analyzed by SDS-PAGE, IEF gel and CD spectroscopy methods. Physicochemical properties, size and zeta potentials, of native and PEGylated hGH were evaluated by Dynamic Light Scattering (DLS) method. Physical and chemical stabilities were assayed at different temperatures (37, 25 and 4 °C) within three weeks by SEC- and RP-HPLC methods, respectively. Results By this preparation method, mono-PEG-hGH was obtained and the secondary structure was unchanged. The DLS results indicated that by PEGylation the size and zeta potentials of the protein were increased and decreased, respectively. These data indicated that PEG chain covered the protein surface. The isoelectric point (pI) of protein was not altered following PEGylation. The results of stability indicated that, the mono-PEG-hGH was considerably more stable especially in elevated temperatures as compared with the non-PEGylated one. Conclusion PEGylation changed the physicochemical properties of hGH and also enhanced the stability of the protein.
Biotechnology Research Center School of Pharmacy Mashhad University of Medical Sciences Mashhad Iran
Department of Pharmaceutics School of Pharmacy Mashhad University of Medical Sciences Mashhad Iran
Medical Chemistry Department School of Pharmacy Mashhad University of Medical Sciences Mashhad Iran
Citace poskytuje Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17012152
- 003
- CZ-PrNML
- 005
- 20170531101653.0
- 007
- ta
- 008
- 170407s2016 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.jab.2016.06.002 $2 doi
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Khameneh, Bahman $u Department of Pharmaceutical Control, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
- 245 10
- $a Evaluation of physicochemical and stability properties of human growth hormone upon enzymatic PEGylation / $c Bahman Khameneh, Mohammad Reza Saberi, Mohammad Hassanzadeh-Khayyat, Hamid Mohammadpanah, Morteza Ghandadi, Mehrdad Iranshahi, Ali Baratian, Mahmoud Reza Jaafari
- 504 __
- $a Literatura
- 520 9_
- $a Background PEGylation is an increasingly important strategy for improving stability, pharmacokinetic and pharmacodynamic properties of proteins. Objective In this study, site-specific PEGylated human growth hormone (hGH) was prepared by microbial transglutaminase and physicochemical and stability properties of bioconjugates were tested. Method hGH was PEGylated by 20 kDa mPEG-NH2. PEG-hGH was purified by size exclusion chromatography method and analyzed by SDS-PAGE, IEF gel and CD spectroscopy methods. Physicochemical properties, size and zeta potentials, of native and PEGylated hGH were evaluated by Dynamic Light Scattering (DLS) method. Physical and chemical stabilities were assayed at different temperatures (37, 25 and 4 °C) within three weeks by SEC- and RP-HPLC methods, respectively. Results By this preparation method, mono-PEG-hGH was obtained and the secondary structure was unchanged. The DLS results indicated that by PEGylation the size and zeta potentials of the protein were increased and decreased, respectively. These data indicated that PEG chain covered the protein surface. The isoelectric point (pI) of protein was not altered following PEGylation. The results of stability indicated that, the mono-PEG-hGH was considerably more stable especially in elevated temperatures as compared with the non-PEGylated one. Conclusion PEGylation changed the physicochemical properties of hGH and also enhanced the stability of the protein.
- 650 12
- $a lidský růstový hormon $x farmakokinetika $x farmakologie $x chemie $7 D019382
- 650 _2
- $a polyethylenglykoly $x farmakokinetika $7 D011092
- 650 _2
- $a nosiče léků $7 D004337
- 650 _2
- $a lékové transportní systémy $7 D016503
- 650 _2
- $a stabilita proteinů $7 D055550
- 650 _2
- $a transglutaminasy $x farmakologie $7 D011503
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Saberi, Mohammad Reza $u Medical Chemistry Department, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
- 700 1_
- $a Hassanzadeh-Khayyat, Mohammad $u Pharmaceutical Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
- 700 1_
- $a Mohammadpanah, Hamid $u Nanotechnology Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
- 700 1_
- $a Ghandadi, Morteza $u Department of Pharmaceutical Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
- 700 1_
- $a Iranshahi, Mehrdad $u Biotechnology Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
- 700 1_
- $a Baratian, Ali $u Department of Pharmaceutics, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
- 700 1_
- $a Jaafari, Mahmoud Reza $u Nanotechnology Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
- 773 0_
- $t Journal of applied biomedicine $x 1214-021X $g Roč. 14, č. 4 (2016), s. 257-264 $w MED00012667
- 856 41
- $u https://jab.zsf.jcu.cz/pdfs/jab/2016/04/02.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b B 2301 $c 1249 $y 4 $z 0
- 990 __
- $a 20170407165424 $b ABA008
- 991 __
- $a 20170531102054 $b ABA008
- 999 __
- $a ok $b bmc $g 1198020 $s 972920
- BAS __
- $a 3
- BMC __
- $a 2016 $b 14 $c 4 $d 257-264 $i 1214-021X $m Journal of Applied Biomedicine $x MED00012667
- LZP __
- $c NLK125 $d 20170530 $a NLK 2017-15/dk